Literature DB >> 29546685

Diagnostic accuracy of transthoracic echocardiography to identify native valve infective endocarditis: a systematic review and meta-analysis.

Mattia Bonzi1, Giulia Cernuschi2, Monica Solbiati2, Giuliano Giusti3, Nicola Montano2, Elisa Ceriani2.   

Abstract

Infective endocarditis (IE) is a serious and potentially life-threatening disease, and accurate diagnosis is essential. We performed a systematic review and meta-analysis to assess the diagnostic accuracy of transthoracic echocardiography (TTE), with transesophageal echocardiography (TEE) as the reference standard, in patients with suspected IE of the native valves. We performed a systematic search in MEDLINE, EMBASE and Cochrane Library searching for studies that enrolled adult patients with suspected native valves IE where data about both TTE and TEE could be extracted. We included 11 studies, for a total of 2209 patients. The overall sensitivity, specificity, negative and positive likelihood ratios (LR) of TTE are 0.71 (95% CI 0.56-0.82), 0.80 (95% CI 0.58-0.92), 0.37 (95% CI 0.20-0.68) and 3.56 (95% CI 1.3-9.72), respectively. The subgroup analyses of the studies considering different cut-off levels show that the strict negative criteria (i.e., managing indeterminate results as positive) have the highest sensitivity and the lowest LR-. On the contrary, when managing indeterminate results as negative (standard criteria), the specificity and LR+ are the highest. We observed no differences between the studies performed with older and more recent technologies. In conclusion, our study results support the use of a negative TTE as a single rule-out test in patients with a low pre-test probability. In selected cases, the use of strict negative criteria might exclude IE in intermediate-risk patients, and a positive TTE might be considered as a single rule-in test with no need for TEE if TEE results would not change the patient's management.

Entities:  

Keywords:  Diagnostic accuracy; Endocarditis; Meta-analysis; Transesophageal echocardiography; Transthoracic echocardiography

Mesh:

Year:  2018        PMID: 29546685     DOI: 10.1007/s11739-018-1831-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  29 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Impact of harmonic imaging on transthoracic echocardiographic identification of infective endocarditis and its complications.

Authors:  F Chirillo; A Pedrocco; A De Leo; A Bruni; O Totis; P Meneghetti; P Stritoni
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

3.  The Italian Society of Internal Medicine choosing wisely campaign.

Authors:  Nicola Montano; Giorgio Costantino; Giovanni Casazza; Rodolfo Sbrojavacca; Marco Vincenzo Lenti; Lorenzo Falsetti; Annasanta Guzzo; Raffaele Majo; Francesco Perticone; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2016-11-01       Impact factor: 3.397

Review 4.  Clinical practice. Infective endocarditis.

Authors:  Bruno Hoen; Xavier Duval
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

5.  Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis.

Authors:  A J Mansur; C M Dal Bó; J T Fukushima; V S Issa; M Grinberg; P M Pomerantzeff
Journal:  Am Heart J       Date:  2001-01       Impact factor: 4.749

6.  A negative transthoracic echocardiogram obviates the need for transesophageal echocardiography in patients with suspected native valve active infective endocarditis.

Authors:  W N Irani; P A Grayburn; I Afridi
Journal:  Am J Cardiol       Date:  1996-07-01       Impact factor: 2.778

7.  An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective Endocarditis.

Authors:  Joseph A Sivak; Amit N Vora; Ann Marie Navar; Phillip J Schulte; Anna Lisa Crowley; Joseph Kisslo; G Ralph Corey; Lawrence Liao; Andrew Wang; Eric J Velazquez; Zainab Samad
Journal:  J Am Soc Echocardiogr       Date:  2016-02-03       Impact factor: 5.251

8.  Transthoracic and transesophageal echocardiography for the indication of suspected infective endocarditis: vegetations, blood cultures and imaging.

Authors:  Vinay Kini; Sachin Logani; Bonnie Ky; Julio A Chirinos; Victor A Ferrari; Martin G St John Sutton; Susan E Wiegers; James N Kirkpatrick
Journal:  J Am Soc Echocardiogr       Date:  2010-04       Impact factor: 5.251

9.  Value of transesophageal echocardiography as an adjunct to transthoracic echocardiography in evaluation of native and prosthetic valve endocarditis.

Authors:  W R Pedersen; M Walker; J D Olson; F Gobel; H W Lange; J A Daniel; J Rogers; T Longe; M Kane; M R Mooney
Journal:  Chest       Date:  1991-08       Impact factor: 9.410

10.  Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach.

Authors:  A Mügge; W G Daniel; G Frank; P R Lichtlen
Journal:  J Am Coll Cardiol       Date:  1989-09       Impact factor: 24.094

View more
  2 in total

1.  An appraisal of clinical practice guidelines for the appropriate use of echocardiography for adult infective endocarditis-the timing and mode of assessment (TTE or TEE).

Authors:  Peihan Xie; Xiaodong Zhuang; Menghui Liu; Shaozhao Zhang; Jia Liu; Donghong Liu; Xinxue Liao
Journal:  BMC Infect Dis       Date:  2021-01-21       Impact factor: 3.090

2.  Point-of-Care Ultrasound (POCUS) as an Extension of the Physical Examination in Patients with Bacteremia or Candidemia.

Authors:  Serafín López Palmero; Miguel Angel López Zúñiga; Virginia Rodríguez Martínez; Raul Reyes Parrilla; Ana Maria Alguacil Muñoz; Waldo Sánchez-Yebra Romera; Patricia Martín Rico; Inmaculada Poquet Catalá; Carlos Jiménez Guardiola; Alfonso Del Pozo Pérez; Ruben Lobato Cano; Ana Maria Lazo Torres; Gines López Martínez; Luis Felipe Díez García; Tesifon Parrón Carreño
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.